Neurology Minute

Dr. Salim Dib discusses the impact circadian rhythm disruption has on overall health.   

Dr. Alison Christy delves into another women's history minute to discuss Mary Whiton Calkins.

Dr. Alex Menze and Dr. Adrian Budhram discuss the clinical utility of cerebrospinal fluid correction factors for traumatic lumbar punctures. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200350  

Dr. Trey Bateman, Dr. Simon Ducharme, and Tristin Best discuss changes in hypothalamic structure across the lifespan in patients with genetic FTD and whether these changes related to sleep dysfunction.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209829  

Dr. Alison Christy delves into another women's history minute to discuss Maria Mikhaĭlovna Manàsseina.

Dr. Alison Christy delves into another women's history minute to discuss the first female neurologist in Puerto Rico - Ana Judith Roman Garcia. 

In part two of a two-part series, Dr. Justin Abbatemarco and Dr. Nicolás Lundahl Ciano-Petersen discuss the associated paraneoplastic syndromes they saw from a neurologic perspective. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200260 

In part one of a two-part series, Dr. Justin Abbatemarco and Dr. Nicolás Lundahl Ciano-Petersen break down Merkel cell carcinoma and discuss what all neurologists need to know about it. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200260 

Dr. Tesha Monteith and Dr. Ashish D. Patel discuss headache referrals and the implementation of a design thinking approach to improve access to headache care. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200336  

In this lab minute, Dr. Stacey Clardy talks about paraneoplastic panels. 

Dr. Stacey Clardy discusses when to test for myasthenia gravis in this lab minute. 

Dr. Stacey Clardy discusses the fundamentals of the immune response to infection and explains how to accurately distinguish between past and current or recent infections.

Dr. Neha Dangayach and Drs. Yelena Bodien and Brian Edlow discuss the concept of cognitive motor dissociation (CMD) in neurocritical care, highlighting its implications for patient assessment and treatment. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200390 

In the final episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss major takeaways from the new guidelines for the primary prevention of stroke.  Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119 

In the fourth episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss stroke prevention in pregnancy.  Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119 

Dr. Andy Southerland and Dr. Scott Friedenberg discuss the significant challenge of financial health within a department or practice, and how it impacts patient and provider satisfaction as well as clinical habits. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200314 

In the third episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the dietary recommendations outlined in the guidelines for primary stroke prevention. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119 

Dr. Shuvro Roy and Dr. Marisa Patryce McGinley discuss outpatient telemedicine utilization for neurologic conditions and identify potential disparities. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200407

In the second episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss the recommendations for patients with high-risk antiphospholipid profile and the increased risk of stroke.  Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119 

In the first episode of this dynamic five-part series, Dr. Hunter Hewitt and Dr. Cheryl Bushnell discuss notable changes in the guidelines compared to previous versions, including the introduction of endometriosis as an inflammatory condition that has been shown to increase the risk of stroke. Show reference: https://www.aan.com/Guidelines/Home/GuidelineDetail/1119